d-alpha tocopherol has been researched along with Pituitary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amarti, A; Belaidi, H; Benomar, A; Birouk, N; Bouslam, N; Chkili, T; Marzouki, N; Ouazzani, R; Yahyaoui, M | 1 |
| Baldassare, M; Buccione, R; Luini, A; Pompeo, A | 1 |
| Braughler, JM; Chase, RL; Day, JS; Hall, ED; Lahti, RA; Neff, GL; Sethy, VH; Yonkers, PA | 1 |
3 other study(ies) available for d-alpha tocopherol and Pituitary Neoplasms
| Article | Year |
|---|---|
Vitamin E deficiency ataxia associated with adenoma.
Topics: Adenoma; Adult; Ataxia; Gene Deletion; Humans; Immunohistochemistry; Male; Microsatellite Repeats; Pedigree; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Vitamin E; Vitamin E Deficiency | 1999 |
Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells.
Topics: Animals; Arachidonic Acid; Cell Division; Cell Size; Cell Survival; Cyclosporine; Dexamethasone; Digitonin; Dose-Response Relationship, Drug; Enzyme Activation; Immunosuppressive Agents; Interleukin-1; Melitten; Mice; Phospholipases A; Phospholipases A2; Pituitary Neoplasms; Tacrolimus; Terpenes; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vitamin E | 1999 |
A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumor (AtT-20) cells.
Topics: Adrenocorticotropic Hormone; Animals; Antioxidants; Arachidonic Acid; Arachidonic Acids; Glucocorticoids; Lipid Peroxides; Male; Mice; Pituitary Neoplasms; Pregnatrienes; Tumor Cells, Cultured; Vitamin E | 1988 |